EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI‐RS 2025

Qi-Xiang Song iD, Sanjay Sinha iD, Bahareh Vahabi iD, Anthony Kanai iD, Christopher Fry iD, Pradeep Tyagi iD, Stefania Musco iD, Dudley Robinson iD, Marcus J Drake iD, Paul Abrams iD, Alan Wein iD, Christopher R Chapple iD

Neurourology and Urodynamics · 2026

DOI: 10.1002/nau.70182 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurourology and Urodynamics, 2026. Verfasst von Qi-Xiang Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Nocturia, Urinary Bladder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: The National Key Research and Development Program of China (2023YFC3606001), National Natural Science Foundation of China (82570910, 82270819)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nocturia is a prevalent condition with systematic etiologies which require multidisciplinary collaborations during diagnosis and management. Here we evaluate current evidence and present unresolved research questions regarding the three key pathophysiological domains of nocturia with respect to a conceptual brain‐kidney‐bladder axis, namely sleep enhancement, extra‐renal water reabsorption and circadian regulation of bladder tissue.

Methods

A Think Tank was convened at the 12th International Consultation on Incontinence Research Society meeting in June 2025, looking at novel therapeutic targets for nocturia. This article synthesizes key deliberations from this meeting session.

Results

The discussion was mainly focused on idiopathic nocturia with an overactive bladder symptom complex or nocturnal polyuria. Firstly, medications and conservative nondrug measures targeting sleep that could potentially improve nocturia were considered. Secondly, investigation of water reabsorption mechanisms within the bladder and the role of small molecule vasopressin receptor type‐2 agonists were examined that may provide novel therapeutic options to rectify nocturnal polyuria. Finally, to address circadian misalignments, organ specific chronotherapies, based on abnormal circadian features of bladder tissues that can be curative for nocturia, were discussed.

Conclusions

The evidence indicates that promising therapeutic modalities targeting the regulation of sleep‐wake cycles, intravesical water transport mechanisms, and circadian patterns of detrusor activity may offer alternative strategies for managing nocturnal polyuria. However, further mechanistic investigations and randomized controlled trials are required to advance these approaches toward clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NocturiaUrinary BladderAnimalsHumansCircadian RhythmPolyuriaReceptors, VasopressinSleepUrinary Bladder, Overactive

Stichwörter der Autor:innen

bladdercircadian rhythmnocturiasleepwater reabsorption

Substanzen

Receptors, Vasopressin

Autor:innen und Institutionen

  • Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Urology, Apollo Hospitals, Hyderabad, India.
  • School of Applied Sciences, University of the West of England, Bristol, UK.
  • Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, USA.
  • School of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, UK.
  • Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Qi-Xiang Song, Sanjay Sinha, Bahareh Vahabi, Anthony Kanai, Christopher Fry, Pradeep Tyagi, Stefania Musco, Dudley Robinson, Marcus J Drake, Paul Abrams, Alan Wein, Christopher R Chapple

Förderung

  • The National Key Research and Development Program of China (2023YFC3606001), National Natural Science Foundation of China (82570910, 82270819).

Zitieren

APA

Song, Q. X., Sinha, S., Vahabi, B., Kanai, A., Fry, C., Tyagi, P., Musco, S., Robinson, D., Drake, M. J., Abrams, P., Wein, A., & Chapple, C. R. (2026). Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI‐RS 2025. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70182

Vancouver

Song QX, Sinha S, Vahabi B, Kanai A, Fry C, Tyagi P, et al. Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI‐RS 2025. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70182

BibTeX
@article{Song2026,
  author = {Song, Qi-Xiang and Sinha, Sanjay and Vahabi, Bahareh and Kanai, Anthony and Fry, Christopher and Tyagi, Pradeep and Musco, Stefania and Robinson, Dudley and Drake, Marcus J and Abrams, Paul and Wein, Alan and Chapple, Christopher R},
  title = {Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI‐RS 2025},
  journal = {Neurourology and Urodynamics},
  year = {2026},
  doi = {10.1002/nau.70182}
}
Kostenlos starten →